Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Endometriosis - How up-to-date is this topic?
Changes

Version 1.3, revision planned in 2013.

Last revised in June 2009

October 2010 — minor update. From mid-October 2010, Nexplanon® will replace Impanon®. Nexplanon® is bioequivalent to Implanon®. The main differences are that Nexplanon® is radio-opaque, and the insertion technique is different [FSRH, 2010]. Issued in October 2010.

September 2010 — minor update. A prescription for Rigevidon®, another new ethinylestradiol plus levonorgestrel combined oral contraceptive pill, has been added. Issued in September 2010.

June 2010 — minor update. A prescription for Levest®, a new ethinylestradiol plus levonorgestrel combined oral contraceptive pill, has been added. Issued in June 2010.

February to June 2009 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.

There are no major changes to the recommendations.

© NHS Institute for Innovation and Improvement